Xiaoyi Li

4PUBLICATIONS
59CO-AUTHORS
Pharmaceutical delivery technologiesPredictive and prognostic markersGlycoconjugatesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Nov 02, 2024
Efficacy and Safety of a Fixed-Dose Combination Gel with Adapalene 0.1% and Clindamycin 1% for the Treatment of Acne Vulgaris (CACTUS): A Randomized, Controlled, Assessor-Blind, Phase III Clinical Trial.

Chao Luan, Wen Lin Yang, Jia Wen Yin

|Dec 05, 2022
First-in-Maintenance Therapy for Localized High-Grade Osteosarcoma: An Open-Label Phase I/II Trial of the Anti-PD-L1 Antibody ZKAB001.

Yan Zhou, Qingcheng Yang, Yang Dong

|Sep 27, 2022
Cyclosporine A (0.05%) Ophthalmic Gel in the Treatment of Dry Eye Disease: A Multicenter, Randomized, Double-Masked, Phase III, COSMO Trial.

Wenyan Peng, Xiuying Jiang, Lei Zhu

|Sep 22, 2022
Efficacy and Safety of the Anti-PD-L1 mAb Socazolimab for Recurrent or Metastatic Cervical Cancer: a Phase I Dose-Escalation and Expansion Study.

Jusheng An, Jie Tang, Benjamin X Li

Pageof 1

Frequent Collaborators

2 joint publications

Xiangrong Dai

1 joint publications

Jusheng An

1 joint publications

Jie Tang

1 joint publications

Huihua Xiong